Seroba Life Sciences
Investor profile
Venture capital
Seroba Life Sciences has backed 9 European tech companies across 10 funding rounds between 2017 and 2025, joining rounds totalling €272M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
10
distinct rounds
Companies
9
backed
Active span
2017–2025
9 yrs
Total round €
€272M
sum of rounds joined
Deals by year
distinct rounds / yearSeroba Life Sciences — deals by year — interactive chart.
Data table
| Seroba Life Sciences — deals by year | |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2025 | 1 |
Top sectors
by dealsSeroba Life Sciences — top sectors — interactive chart.
Data table
| Seroba Life Sciences — top sectors | |
|---|---|
| Healthtech | 10 |
Stages
by dealsSeroba Life Sciences — stages — interactive chart.
Data table
| Seroba Life Sciences — stages | |
|---|---|
| Series A | 4 |
| Series B | 4 |
| Series C | 1 |
| Other | 1 |
Countries
by dealsSeroba Life Sciences — countries — interactive chart.
Data table
| Seroba Life Sciences — countries | |
|---|---|
| Ireland | 3 |
| France | 2 |
| UK | 2 |
| Germany | 1 |
| Italy | 1 |
| Spain | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Cambridge Innovation Capital2
- FundPlus2
- Kurma Partners2
- Omnes Capital2
- V-Bio Ventures2
- 3B Future Health Fund1
- BioGeneration Ventures1
- Bpifrance1
- btov Partners1
- Caixa Capital Risc1
- CDP Venture Capital1
- Claris Ventures1
- Edmond de Rothschild Venture Capital1
- eureKARE1
- Evolution Ventures1
- Fast Track Initiative1
- Forbion1
- GIMV1
- Go Capital1
- Hadean Ventures1
- IDInvest Partners1
- Indaco Venture Partners1
- Innogest Capital1
- Invus1
- IP Group PLC1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Complement Therapeutics | Germany | 1 | €72M |
| Coave Therapeutics | France | 2 | €53M |
| Quanta | UK | 1 | €42M |
| Medlumics | Spain | 1 | €34M |
| Storm Therapeutics | UK | 1 | €28M |
| Sibylla Biotech | Italy | 1 | €23M |
| Palliare | Ireland | 1 | €8.0M |
| Shorla Pharma | Ireland | 1 | €7.4M |
| Deciphex | Ireland | 1 | €3.9M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Complement Therapeutics | Series A | €72M | 2023-04 |
| Quanta | Series C | €42M | 2019-07 |
| Medlumics | Series B | €34M | 2017-03 |
| Coave Therapeutics | Series A | €32M | 2025-01 |
| Storm Therapeutics | Series B | €28M | 2022-12 |
| Sibylla Biotech | Series A | €23M | 2022-10 |
| Coave Therapeutics | Series B | €21M | 2021-07 |
| Palliare | Other | €8.0M | 2021-07 |
| Shorla Pharma | Series A | €7.4M | 2020-03 |
| Deciphex | Series B | €3.9M | 2023-01 |